IS3570A7 - Aðferð við framleiðslu á efnasamsetningu sem gerð er úr uppbótarefnum (3-substistuted) og kristalsamböndum (2-oxindole) - Google Patents

Aðferð við framleiðslu á efnasamsetningu sem gerð er úr uppbótarefnum (3-substistuted) og kristalsamböndum (2-oxindole)

Info

Publication number: IS3570A7
Authority: IS; Iceland
Prior art keywords: oxindole; additives; substituted; preparation; chemical composition
Prior art date: 1989-04-18

Application number

IS3570A

Other languages

English (en)

Other versions

IS1636B (is

Inventor

Jacob Ehrgott Frederick

Joseph Goddard Carl

Richard Schulte Gary

Original Assignee

Pfizer Inc.

Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)

1989-04-18

Filing date

1990-04-09

Publication date

1990-10-19

1990-04-09 Application filed by Pfizer Inc. filed Critical Pfizer Inc.

1990-10-19 Publication of IS3570A7 publication Critical patent/IS3570A7/is

1996-09-20 Publication of IS1636B publication Critical patent/IS1636B/is

Classifications

- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D401/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom
- C07D401/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings
- C07D401/06—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, at least one ring being a six-membered ring with only one nitrogen atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P19/00—Drugs for skeletal disorders
- A61P19/02—Drugs for skeletal disorders for joint disorders, e.g. arthritis, arthrosis
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P25/00—Drugs for disorders of the nervous system
- A61P25/04—Centrally acting analgesics, e.g. opioids
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P29/00—Non-central analgesic, antipyretic or antiinflammatory agents, e.g. antirheumatic agents; Non-steroidal antiinflammatory drugs [NSAID]
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P3/00—Drugs for disorders of the metabolism
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P9/00—Drugs for disorders of the cardiovascular system
- A61P9/06—Antiarrhythmics
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D209/00—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom
- C07D209/02—Heterocyclic compounds containing five-membered rings, condensed with other rings, with one nitrogen atom as the only ring hetero atom condensed with one carbocyclic ring
- C07D209/04—Indoles; Hydrogenated indoles
- C07D209/30—Indoles; Hydrogenated indoles with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, directly attached to carbon atoms of the hetero ring
- C07D209/32—Oxygen atoms
- C07D209/34—Oxygen atoms in position 2
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D333/00—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom
- C07D333/02—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings
- C07D333/04—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom
- C07D333/26—Heterocyclic compounds containing five-membered rings having one sulfur atom as the only ring hetero atom not condensed with other rings not substituted on the ring sulphur atom with hetero atoms or with carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals, directly attached to ring carbon atoms
- C07D333/38—Carbon atoms having three bonds to hetero atoms with at the most one bond to halogen, e.g. ester or nitrile radicals
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D403/00—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00
- C07D403/02—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings
- C07D403/04—Heterocyclic compounds containing two or more hetero rings, having nitrogen atoms as the only ring hetero atoms, not provided for by group C07D401/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D405/00—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom
- C07D405/02—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings
- C07D405/06—Heterocyclic compounds containing both one or more hetero rings having oxygen atoms as the only ring hetero atoms, and one or more rings having nitrogen as the only ring hetero atom containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D407/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00
- C07D407/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings
- C07D407/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having oxygen atoms as the only ring hetero atoms, not provided for by group C07D405/00 containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D409/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms
- C07D409/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings
- C07D409/06—Heterocyclic compounds containing two or more hetero rings, at least one ring having sulfur atoms as the only ring hetero atoms containing two hetero rings linked by a carbon chain containing only aliphatic carbon atoms
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
- C07D413/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings
- C07D413/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/02—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings
- C07D417/04—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing two hetero rings directly linked by a ring-member-to-ring-member bond
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
- C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings

Landscapes

Chemical & Material Sciences (AREA)
Organic Chemistry (AREA)
Health & Medical Sciences (AREA)
Veterinary Medicine (AREA)
Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
Public Health (AREA)
General Health & Medical Sciences (AREA)
Chemical Kinetics & Catalysis (AREA)
General Chemical & Material Sciences (AREA)
Medicinal Chemistry (AREA)
Animal Behavior & Ethology (AREA)
Pharmacology & Pharmacy (AREA)
Life Sciences & Earth Sciences (AREA)
Bioinformatics & Cheminformatics (AREA)
Engineering & Computer Science (AREA)
Rheumatology (AREA)
Pain & Pain Management (AREA)
Hematology (AREA)
Cardiology (AREA)
Immunology (AREA)
Physical Education & Sports Medicine (AREA)
Diabetes (AREA)
Orthopedic Medicine & Surgery (AREA)
Obesity (AREA)
Heart & Thoracic Surgery (AREA)
Biomedical Technology (AREA)
Neurology (AREA)
Neurosurgery (AREA)
Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Plural Heterocyclic Compounds (AREA)
Indole Compounds (AREA)
Heterocyclic Compounds Containing Sulfur Atoms (AREA)

IS3570A 1989-04-18 1990-04-09 Aðferð við framleiðslu á efnasamsetningu sem gerðer úr uppbótarefnum (3-substistuted) og kristalsamböndum (2-oxindole) IS1636B (is)

Applications Claiming Priority (1)

Application Number	Priority Date	Filing Date	Title
US34011389A	1989-04-18	1989-04-18

Publications (2)

Publication Number	Publication Date
IS3570A7 true IS3570A7 (is)	1990-10-19
IS1636B IS1636B (is)	1996-09-20

Family

ID=23331948

Family Applications (1)

Application Number	Title	Priority Date	Filing Date
IS3570A IS1636B (is)	1989-04-18	1990-04-09	Aðferð við framleiðslu á efnasamsetningu sem gerðer úr uppbótarefnum (3-substistuted) og kristalsamböndum (2-oxindole)

Country Status (33)

Country	Link
US (4)	US5047554A (is)
EP (1)	EP0393936B1 (is)
JP (2)	JP2506478B2 (is)
KR (1)	KR920006394B1 (is)
CN (1)	CN1022832C (is)
AP (1)	AP142A (is)
AT (1)	ATE118767T1 (is)
AU (1)	AU633767B2 (is)
BG (1)	BG60646B1 (is)
CA (1)	CA2014467C (is)
CZ (1)	CZ284340B6 (is)
DD (1)	DD293822A5 (is)
DE (1)	DE69017066T2 (is)
DK (1)	DK0393936T3 (is)
EG (1)	EG19122A (is)
ES (1)	ES2068334T3 (is)
FI (1)	FI106378B (is)
GR (1)	GR3015811T3 (is)
HU (2)	HUT58314A (is)
IE (1)	IE65091B1 (is)
IL (3)	IL94047A (is)
IS (1)	IS1636B (is)
MA (1)	MA21808A1 (is)
MX (1)	MX20359A (is)
NO (1)	NO176759C (is)
NZ (1)	NZ233320A (is)
OA (1)	OA09205A (is)
PL (2)	PL163951B1 (is)
PT (1)	PT93785B (is)
RO (1)	RO106402B1 (is)
RU (2)	RU2039042C1 (is)
YU (1)	YU47588B (is)
ZA (1)	ZA902871B (is)

Families Citing this family (45)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
SK278175B6 (en) *	1988-10-18	1996-03-06	Pfizer	3-acyl-2-oxindole-1-carboxamides and method of their preparation
DE68923673T2 (de) *	1988-10-18	1996-01-18	Pfizer	Prodrogen von antiinflammatorischen 3-Acyl-2-oxindol-1-carboxamiden.
US5047554A (en) *	1989-04-18	1991-09-10	Pfizer Inc.	3-substituted-2-oxindole derivatives
IL95880A (en) *	1989-10-13	1995-12-31	Pfizer	Use of 3-Transformed History of 2-Oxindole for the Preparation of Pharmaceuticals for Inhibition of Interlaukio-1 Biosynthesis
US5064851A (en) *	1990-07-24	1991-11-12	Pfizer Inc.	3-(1-substituted-pyrazoyl)-2-oxindole derivatives, compositions and use
TW438798B (en) *	1992-10-07	2001-06-07	Pfizer	3-substituted 2-oxindole-1-carboxamide pharmaceutical compositions
CZ131695A3 (en) *	1992-11-23	1996-05-15	Pfizer	Process for preparing 4-chloro-2-thiophenecarboxylic acid, intermediates for its preparation and process for preparing 5-fluoro-6-chloro-3-(4-chloro-2-thenoyl)-2-oxindole-1-carboxamide
US5298522A (en) *	1993-01-22	1994-03-29	Pfizer Inc.	6-chloro-5-fluoro-3-(2-thenoyl)-2-oxindole-1-carboxamide as an analgesic and anti-inflammatory agent while maintaining a normal urine protein/creatinine ratio
US5607959A (en) *	1993-02-09	1997-03-04	Pfizer Inc.	Oxindole 1-[N-(alkoxycarbonyl) ] carboxamides and 1-(N-carboxamido) carboxamides as antiinflammatory agents
ES2076106B1 (es) *	1993-08-26	1996-06-16	Pfizer	Composiciones farmaceuticas a base de 2-oxindol-1-carboxamidas 3-sustituidas
US5783664A (en) *	1993-09-17	1998-07-21	Smithkline Beecham Corporation	Cytokine suppressive anit-inflammatory drug binding proteins
EP0679396A1 (en) *	1994-03-02	1995-11-02	Pfizer Inc.	Use of 3-substituted-2-oxidole-1-carboxamides for the manufacture of a medicament in the treatment and prevention of ischemia induced myocardial injury and cytokine mediated myocardial injury
CN1051452C (zh) *	1994-07-26	2000-04-19	中国医学科学院血液学研究所	3-取代芳基氧化吲哚类化合物的应用
US5545656A (en) *	1995-04-05	1996-08-13	Pfizer Inc.	2-Oxidole-1-carboxamide pharmaceutical agents for the treatment of alzheimer's disease
AU7503496A (en) *	1995-12-19	1997-07-14	Pfizer Inc.	Stable, long acting salts of indole derivatives for the treatment of joint diseases
EP0826685A1 (en) *	1996-08-21	1998-03-04	Pfizer Inc.	Stable, long acting salts of carboxamides for the treatment of joint disease
WO1998045282A1 (en) *	1997-04-04	1998-10-15	Pfizer Inc.	Processes and intermediates for preparing 2-fluorothiophene derivatives
US6291514B1 (en)	1998-02-09	2001-09-18	3-Dimensional Pharmaceuticals, Inc.	Heteroaryl amidines, methylamidines and guanidines, preparation thereof, and use thereof as protease inhibitors
GB9818641D0 (en) *	1998-08-26	1998-10-21	Rh Ne Poulenc Rorer Limited	Chemical compounds
US6649645B1 (en)	1998-12-23	2003-11-18	Pharmacia Corporation	Combination therapy of radiation and a COX-2 inhibitor for treatment of neoplasia
US6509334B1 (en)	1999-05-04	2003-01-21	American Home Products Corporation	Cyclocarbamate derivatives as progesterone receptor modulators
US6355648B1 (en)	1999-05-04	2002-03-12	American Home Products Corporation	Thio-oxindole derivatives
SK287142B6 (sk) *	2000-02-15	2010-01-07	Sugen, Inc.	Inhibítory proteínkináz na báze pyrolom substituovaného 2-indolinónu, farmaceutický prípravok s ich obsahom a ich použitie
JP4292742B2 (ja) *	2000-03-09	2009-07-08	小野薬品工業株式会社	インドール誘導体、その製造方法および用途
AU2002230056A1 (en) *	2001-01-29	2002-08-12	Insight Strategy And Marketing Ltd	Indole derivatives and their uses as heparanase inhibitors
AR042586A1 (es) *	2001-02-15	2005-06-29	Sugen Inc	3-(4-amidopirrol-2-ilmetiliden)-2-indolinona como inhibidores de la protein quinasa; sus composiciones farmaceuticas; un metodo para la modulacion de la actividad catalitica de la proteinquinasa; un metodo para tratar o prevenir una afeccion relacionada con la proteinquinasa
WO2002070478A1 (en) *	2001-03-06	2002-09-12	Astrazeneca Ab	Indolone derivatives having vascular-damaging activity
WO2003031438A1 (en)	2001-10-10	2003-04-17	Sugen, Inc.	3-[4-(substituted heterocyclyl)-pyrrol-2-ylmethylidene]-2-indolinone derivatives as kinase inhibitors
MXPA04010397A (es) *	2002-04-22	2005-02-17	Pfizer Prod Inc	Inhibidores selectivos de la ciclooxigenasa-2.
US7728013B2 (en)	2005-05-10	2010-06-01	Intermune, Inc.	Method of modulating stress-activated protein kinase system
AR060403A1 (es) *	2006-04-12	2008-06-11	Sanofi Aventis	Compuestos de amino- pirimidina 2,6- sustituidos -4- monosustituidos como antagonistas del receptor de prostaglandina d2
EP2182809B1 (en)	2007-08-27	2018-01-17	Dart Neuroscience (Cayman) Ltd	Therapeutic isoxazole compounds
ES2567283T3 (es)	2008-06-03	2016-04-21	Intermune, Inc.	Compuestos y métodos para tratar trastornos inflamatorios y fibróticos
MY205872A (en)	2009-04-29	2024-11-18	Amarin Pharmaceuticals Ie Ltd	Pharmaceutical compositions comprising omega-3 fatty acids
US8933248B2 (en)	2012-06-21	2015-01-13	Council Of Scientific & Industrial Research	3-substituted-3-hydroxy oxindole derivatives and process for preparation thereof
AR092742A1 (es)	2012-10-02	2015-04-29	Intermune Inc	Piridinonas antifibroticas
CA2943363A1 (en)	2014-04-02	2015-10-08	Intermune, Inc.	Anti-fibrotic pyridinones
EP3151669B1 (en)	2014-06-06	2020-10-28	Basf Se	Use of substituted oxadiazoles for combating phytopathogenic fungi
WO2016150937A1 (en)	2015-03-25	2016-09-29	Lonza Ltd	Method for preparation of thiophenecarbonyl chlorides
AR106679A1 (es)	2015-11-13	2018-02-07	Basf Se	Oxadiazoles sustituidos para combatir hongos fitopatógenos
EP3373735A1 (en)	2015-11-13	2018-09-19	Basf Se	Substituted oxadiazoles for combating phytopathogenic fungi
MX2018006244A (es)	2015-11-19	2018-11-09	Basf Se	Oxadiazoles sustituidos para combatir hongos fitopatogenos.
US10986839B2 (en)	2016-04-11	2021-04-27	Basf Se	Substituted oxadiazoles for combating phytopathogenic fungi
CN108299354A (zh) *	2017-01-12	2018-07-20	中国科学院宁波材料技术与工程研究所	一种2,5-呋喃二甲酸或其酯化物的制备方法
CN115403566B (zh) *	2022-09-21	2024-01-30	山东大学	3-取代吲哚-2-酮化合物及其制备方法和应用

Family Cites Families (17)

* Cited by examiner, † Cited by third party
Publication number	Priority date	Publication date	Assignee	Title
US1255658A (en) *	1917-11-12	1918-02-05	Adamson Stephens Mfg Co	Carrier for belt conveyers.
BE756447A (fr) *	1969-10-15	1971-03-22	Pfizer	Oxindolecarboxamides
US3900563A (en) *	1973-06-18	1975-08-19	American Cyanamid Co	Method of using 3-(2-(4-phenyl-1-piperazinyl)ethyl)-indolines
US4721712A (en) *	1984-06-12	1988-01-26	Pfizer Inc.	1,3-disubstituted 2-oxindoles as analgesic and anti-inflammatory agents
US4556672A (en) *	1984-03-19	1985-12-03	Pfizer Inc.	3-Substituted 2-oxindole-1-carboxamides as analgesic and anti-inflammatory agents
IN162090B (is) *	1984-03-19	1988-03-26	Pfizer
US4569942A (en) *	1984-05-04	1986-02-11	Pfizer Inc.	N,3-Disubstituted 2-oxindole-1-carboxamides as analgesic and antiinflammatory agents
IN161509B (is) *	1984-05-04	1987-12-19	Pfizer
HU203238B (en) *	1984-08-24	1991-06-28	Pfizer	Process for producing antiinflammatory tricyclic oxindole derivatives
US4808601A (en) *	1984-09-19	1989-02-28	Pfizer Inc.	Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds
US4690943A (en) *	1984-09-19	1987-09-01	Pfizer Inc.	Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds
FI80270C (fi) *	1984-09-19	1990-05-10	Pfizer	Foerfarande foer framstaellning av analgetiska och anti-inflammatoriska 1,3-diacyl-2-oxoindol-foereningar och mellanprodukter.
US4752609A (en) *	1985-06-20	1988-06-21	Pfizer Inc.	Analgesic and antiinflammatory 1,3-diacyl-2-oxindole compounds
EP0409825A1 (en) *	1986-11-14	1991-01-30	HERMAS, Kalervo Alfred August	Lens for receiving and/or transmitting infrared radiation
US4962117A (en) *	1987-11-25	1990-10-09	Merck Frosst Canada, Inc.	Heterazole dialkanoic acids
US4861794A (en) *	1988-04-13	1989-08-29	Pfizer Inc.	3-substituted-2-oxindole-1-carboxamides as inhibitors of interleukin-1 biosynthesis
US5047554A (en) *	1989-04-18	1991-09-10	Pfizer Inc.	3-substituted-2-oxindole derivatives

1990
- 1990-01-31 US US07/473,266 patent/US5047554A/en not_active Expired - Lifetime
- 1990-04-08 IL IL9404790A patent/IL94047A/en not_active IP Right Cessation
- 1990-04-08 IL IL110173A patent/IL110173A/xx not_active IP Right Cessation
- 1990-04-09 AP APAP/P/1990/000175A patent/AP142A/en active
- 1990-04-09 IS IS3570A patent/IS1636B/is unknown
- 1990-04-12 DK DK90303992.3T patent/DK0393936T3/da active
- 1990-04-12 CZ CS901848A patent/CZ284340B6/cs not_active IP Right Cessation
- 1990-04-12 OA OA59776A patent/OA09205A/xx unknown
- 1990-04-12 NZ NZ233320A patent/NZ233320A/xx unknown
- 1990-04-12 EP EP90303992A patent/EP0393936B1/en not_active Expired - Lifetime
- 1990-04-12 CA CA002014467A patent/CA2014467C/en not_active Expired - Fee Related
- 1990-04-12 DE DE69017066T patent/DE69017066T2/de not_active Expired - Fee Related
- 1990-04-12 AT AT90303992T patent/ATE118767T1/de not_active IP Right Cessation
- 1990-04-12 ES ES90303992T patent/ES2068334T3/es not_active Expired - Lifetime
- 1990-04-16 BG BG91773A patent/BG60646B1/bg unknown
- 1990-04-17 PT PT93785A patent/PT93785B/pt not_active IP Right Cessation
- 1990-04-17 ZA ZA902871A patent/ZA902871B/xx unknown
- 1990-04-17 PL PL90287812A patent/PL163951B1/pl unknown
- 1990-04-17 KR KR1019900005296A patent/KR920006394B1/ko not_active Expired
- 1990-04-17 RO RO144837A patent/RO106402B1/ro unknown
- 1990-04-17 HU HU902462A patent/HUT58314A/hu unknown
- 1990-04-17 PL PL90284817A patent/PL163941B1/pl unknown
- 1990-04-17 MA MA22068A patent/MA21808A1/fr unknown
- 1990-04-17 YU YU75590A patent/YU47588B/sh unknown
- 1990-04-17 NO NO901684A patent/NO176759C/no not_active IP Right Cessation
- 1990-04-17 FI FI901915A patent/FI106378B/fi not_active IP Right Cessation
- 1990-04-17 CN CN90102176A patent/CN1022832C/zh not_active Expired - Fee Related
- 1990-04-18 MX MX2035990A patent/MX20359A/es unknown
- 1990-04-18 IE IE136090A patent/IE65091B1/en not_active IP Right Cessation
- 1990-04-18 DD DD90339845A patent/DD293822A5/de not_active IP Right Cessation
- 1990-04-18 JP JP2102775A patent/JP2506478B2/ja not_active Expired - Fee Related
- 1990-04-18 EG EG23590A patent/EG19122A/xx active
1991
- 1991-06-05 US US07/712,169 patent/US5290802A/en not_active Expired - Fee Related
- 1991-10-01 RU SU5001607/04A patent/RU2039042C1/ru not_active IP Right Cessation
1992
- 1992-01-28 AU AU10510/92A patent/AU633767B2/en not_active Ceased
- 1992-01-31 RU SU925010870A patent/RU2073671C1/ru active
1993
- 1993-11-04 US US08/148,764 patent/US5919809A/en not_active Expired - Fee Related
1994
- 1994-06-30 IL IL11017394A patent/IL110173A0/xx unknown
- 1994-08-08 JP JP6186078A patent/JP2581525B2/ja not_active Expired - Fee Related
1995
- 1995-04-17 GR GR950400941T patent/GR3015811T3/el unknown
- 1995-06-07 US US08/477,729 patent/US6174883B1/en not_active Expired - Fee Related
- 1995-06-23 HU HU95P/P00430P patent/HU211150A9/hu unknown

Also Published As

Publication number	Publication date
MX20359A (es)	1994-02-28
IS1636B (is)	1996-09-20
JP2506478B2 (ja)	1996-06-12
IL94047A (en)	1995-10-31
NZ233320A (en)	1991-09-25
AU621477B2 (en)	1992-03-12
CZ284340B6 (cs)	1998-10-14
RU2039042C1 (ru)	1995-07-09
YU75590A (sh)	1992-07-20
JP2581525B2 (ja)	1997-02-12
DE69017066T2 (de)	1995-06-14
EP0393936B1 (en)	1995-02-22
US6174883B1 (en)	2001-01-16
DE69017066D1 (de)	1995-03-30
GR3015811T3 (en)	1995-07-31
IE65091B1 (en)	1995-10-04
BG60646B1 (bg)	1995-11-30
PL163941B1 (pl)	1994-05-31
FI901915A0 (fi)	1990-04-17
KR920006394B1 (ko)	1992-08-06
AP9000175A0 (en)	1990-04-30
ATE118767T1 (de)	1995-03-15
CN1046525A (zh)	1990-10-31
ES2068334T3 (es)	1995-04-16
EP0393936A1 (en)	1990-10-24
NO901684D0 (no)	1990-04-17
US5919809A (en)	1999-07-06
IE901360L (en)	1990-10-18
HUT58314A (en)	1992-02-28
NO176759C (no)	1995-05-24
NO176759B (no)	1995-02-13
FI106378B (fi)	2001-01-31
ZA902871B (en)	1991-11-27
US5290802A (en)	1994-03-01
DK0393936T3 (da)	1995-06-26
AU633767B2 (en)	1993-02-04
AU1051092A (en)	1992-04-09
RU2073671C1 (ru)	1997-02-20
PT93785B (pt)	1996-09-30
HU902462D0 (en)	1990-08-28
AU5362690A (en)	1990-11-22
MA21808A1 (fr)	1990-12-31
PT93785A (pt)	1990-11-20
IL110173A0 (en)	1994-10-07
PL284817A1 (en)	1991-03-25
OA09205A (en)	1992-06-30
BG91773A (bg)	1993-12-24
CA2014467C (en)	2000-02-08
NO901684L (no)	1990-10-19
PL287812A1 (en)	1991-07-15
YU47588B (sh)	1995-10-24
DD293822A5 (de)	1991-09-12
CA2014467A1 (en)	1990-10-18
JPH07118261A (ja)	1995-05-09
RO106402B1 (ro)	1993-04-30
KR900016189A (ko)	1990-11-12
PL163951B1 (pl)	1994-05-31
IL110173A (en)	1997-06-10
US5047554A (en)	1991-09-10
JPH02292258A (ja)	1990-12-03
CN1022832C (zh)	1993-11-24
HU211150A9 (en)	1995-10-30
CZ184890A3 (cs)	1998-07-15
EG19122A (en)	1994-07-30
AP142A (en)	1991-09-26
IL94047A0 (en)	1991-01-31

Publication	Publication Date	Title
IS3570A7 (is)	1990-10-19	Aðferð við framleiðslu á efnasamsetningu sem gerð er úr uppbótarefnum (3-substistuted) og kristalsamböndum (2-oxindole)
NO842340L (no)	1984-12-14	Fremgangsmaate og sammensetninger for frakturering av underjordiske formasjoner
DK664887A (da)	1988-06-23	3-substituerede 3-aroyloxy-propanaminer og fremgangsmaade til fremstilling deraf
NO893559D0 (no)	1989-09-05	Flamme- og roekhemmende blanding for isolasjon av traad og kontakter.
PT86974A (pt)	1988-04-01	Process for the preparation of imidazol compounds and of biociddal compositions containing the same
GR80171B (en)	1985-01-02	N-(2-nitrophenyl)-4-aminopyrimidine derivatives process for the preparation thereof and use
NO172950C (no)	1993-10-06	Framgangsmaate og apparat for broennboring
NO875259L (no)	1988-06-20	Fremgangsmaate og anordning for fremstilling av syntesegass
DK566484A (da)	1985-07-05	Dihydropyridinderivat og fremgangsmaade til fremstilling deraf
DK456884A (da)	1985-03-27	Sammensaetning og fremgangsmaade til fremstilling af vandige borevaeskeadditiver
NO168124C (no)	1992-01-15	Innretning og fremgangsmaate for innfoering og blanding paa stedet av hydroksyaluminium i kvikkleire
NO884416L (no)	1989-04-07	Krystallinsk beta-laktamhydrat og fremgangsmaate for fremstilling derav.
NO172059C (no)	1993-06-02	Fremgangsmaate til hydrokrakking av hydrokarboner og apparat til utfoerelse av fremgangsmaaten
NO845005L (no)	1985-06-17	Fremgangsmaate for fremstilling av antibiotikum l 17392 (deglukoteicoplanin) og salter derav
NO159436C (no)	1988-12-28	Stabilisert beleggingsblanding og fremgangsmaate til belegging av glassbeholdere med tinnoksid.
NO171045C (no)	1993-01-20	Anordning og fremgangsmaate for fremstilling av syntesegass
GB2202876B (en)	1991-02-20	Cementing aggregate apparatus and method
DK108190D0 (da)	1990-05-01	Stereoselektiv fremstilling af 3-substituerede 4-(phenylanilo)piperidinforbindelser og derivater
NO884447L (no)	1989-04-10	Fremgangsmaate for maling under vann og anordning for paafoering av malingen.
FI870565L (fi)	1987-08-13	Halogenoitujen imidien valmistusmenetelmä, niitä sisältävät koostumukset ja niiden käyttö tulenkestäviksi tekevinä aineina
NO901272D0 (no)	1990-03-20	Sammensetning og fremgangsmaate for fjerning av sulfider.
NO162992C (no)	1990-03-21	Prosess for fremstilling av roere og blandingsanordning for fremstillingen av roeren.
NO942531D0 (no)	1994-07-05	Fremgangsmåte for fremstilling av 3-acylöstratriener og acylbenzener
NO159764C (no)	1989-02-08	Fremgangsmaate og anordning ved fremstilling av pariserpoteter.
NO921168L (no)	1992-05-29	Fremgangsmaate og anordning for fremstilling av elementaertjod i ren form